Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb029dca1e6a78623157be7f17895468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a074e5e13bd092105d9c1020e16ff37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21ed8a683bee254dc8138e663955e530 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2008-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c314cdd578150b3fa923256221646b69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1a6e0210bf893299578366419770a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11d74946a2c1ab8d8680296bebcf99a4 |
publicationDate |
2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008234236-A1 |
titleOfInvention |
Reduction of adverse events after percutaneous intervention by use of a thrombin receptor antagonist |
abstract |
Disclosed are methods of preventing adverse clinical events in a patient undergoing a percutaneous coronary intervention procedure or a peripheral percutaneous interventional procedure comprising administering a therapeutically effective amount of a thrombin receptor antagonist, such as SCH 530348, to the patient. Administration of a loading dose of about 40 mg of SCH 530348 in as little as one hour prior to the procedure can result in therapeutically effective levels of platelet aggregation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014210388-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3061460-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2488026-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2990051-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010093629-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9140684-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2488026-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010144339-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011041217-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009297576-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9213024-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008031943-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10006900-B2 |
priorityDate |
2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |